We recently showed that DYRK1A is significantly upregulated in late stages (IIIA to IVB) colorectal tumors and that its high expression correlates to a very poor prognosis for colon cancer patients, suggesting a role in promoting tumorigenesis in these tumors21. Here, DYRK1A is linked to malignant colon neoplasm.